RPG Life Sciences Limited has announced the cessation of Ms. Zahabiya Khorakiwala as an Independent Director, effective July 26, 2026. The departure marks the conclusion of her second consecutive five-year term on the Board. This change triggers a reconstitution of the Sustainability and Corporate Social Responsibility Committee, altering the governance structure for environmental and social oversight within the company.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing also references compliance with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Rajesh Shirambekar, Head – Legal & Company Secretary, signed the disclosure submitted to both the National Stock Exchange of India Limited and BSE Limited on July 27, 2026.

Committee Reconstitution

Following Ms. Khorakiwala’s exit, she ceased to be a member of the Sustainability and Corporate Social Responsibility Committee. The Board reconstituted this committee effective July 27, 2026. The new composition places Ms. Radhika Gupta in the leadership role, with Mr. Sachin Nandgaonkar and Mr. Ashok Nair serving as members.

Director Details

Ms. Zahabiya Khorakiwala, identified by DIN 00102689, served her full term without incident or early resignation. The company confirmed that the reason for the change in directorship was strictly the completion of the statutory maximum tenure for independent directors under current regulations.

What the Numbers Show

The exit of an independent director after two consecutive terms is a standard regulatory requirement designed to ensure fresh perspectives on corporate governance boards. For RPG Life Sciences, this transition ensures compliance with SEBI’s norms on board rotation while maintaining continuity through the immediate reconstitution of key committees. The appointment of Ms. Radhika Gupta as Chairperson of the Sustainability and Corporate Social Responsibility Committee signals the company’s continued focus on ESG governance structures despite the personnel change.

RPG Life Sciences shareholders approved a final dividend of ₹24 per equity share for the financial year ended March 31, 2026, during its 19th Annual General Meeting (AGM) held on July 23, 2026. The resolution passed with overwhelming support, reflecting strong shareholder confidence in the company’s capital return strategy. The meeting also addressed key governance matters, including the reappointment of directors and the ratification of cost auditor remuneration.

The AGM was conducted via video conferencing in compliance with Ministry of Corporate Affairs (MCA) and SEBI circulars. Harsh V. Goenka, Chairman of the company, presided over the proceedings. The quorum was established with 20 promoters and 20 public shareholders attending virtually. Statutory auditors SRBC & Co. LLP and secretarial auditors Parikh Parekh & Associates were represented at the meeting. Mitesh Dhaliwala of Parikh Parekh & Associates served as the scrutinizer for the voting process.

All six resolutions placed before the members were passed with the requisite majority. The most significant outcome was the declaration of a 300% dividend on equity shares with a face value of ₹8 each. This ordinary resolution received 100% support from votes polled, with only six votes cast against it out of more than 13 million total votes.

Key Resolutions Passed

Shareholders voted on several critical items concerning board composition and statutory appointments. The voting results, scrutinized by Parikh Parekh & Associates, are detailed below:

Harsh V. Goenka and Manoj Maheshwari were reappointed as Non-Executive Non-Independent Directors upon retirement by rotation under Section 152(6) of the Companies Act, 2013. Both resolutions secured nearly unanimous support, with approximately 87,754 votes cast against each appointment out of 13.1 million votes polled.

Dr. Pratit Samdani was appointed as an Independent Director for a five-year term commencing April 29, 2026, and ending April 28, 2031. This special resolution passed with 99.99% approval, indicating minimal dissent among the shareholder base.

Governance and Compliance

The company ratified the remuneration payable to Kirit Mehta & Co., its cost auditors, for the financial year ending March 31, 2027. This ordinary resolution was approved with 100% of the votes polled in favor.

The voting process utilized the National Securities Depository Limited (NSDL) e-voting platform. Remote e-voting commenced on July 20, 2026, and concluded on July 22, 2026. Shareholders present at the virtual AGM who had not voted remotely were given an additional 15 minutes to cast their ballots. The cut-off date for voting eligibility was July 16, 2026, with a total of 24,393 shareholders on record. The meeting concluded at 3:38 p.m., following the closure of the e-voting window.